Anna Rosell Novel Graduated in Biology (2001) and PhD in Medicine (2005), both at Universitat Autònoma de Barcelona. My scientific education and expertise has been focused in the translational study of stroke disease and therapies. I obtained a Miguel Servet research position in 2010 from the Spanish National Institute of Health and Research Agency (Instituto Carlos III), and since February 2016 I hold a Tenure position at VHIR as Principal Investigator and Head of the Neurovascular Research Laboratory. Institutions of which they are part Head of group Neurovascular Diseases Vall Hebron Institut de Recerca Email Anna Rosell Novel Email Institutions of which they are part Head of group Neurovascular Diseases Vall Hebron Institut de Recerca Graduated in Biology (2001) and PhD in Medicine (2005), both at Universitat Autònoma de Barcelona. My scientific education and expertise has been focused in the translational study of stroke disease and therapies. I obtained a Miguel Servet research position in 2010 from the Spanish National Institute of Health and Research Agency (Instituto Carlos III), and since February 2016 I hold a Tenure position at VHIR as Principal Investigator and Head of the Neurovascular Research Laboratory.
As a PhD student at Vall d’Hebron Research Institute (VHIR) I was trained in the biomarkers field and clinical stroke studies, which gave me a solid understanding of the disease from a clinical perspective. After I moved to the United States for a Postdoctoral position at the Massachusetts General Hospital in a world-leading laboratory recognized for their experimental studies in cerebral ischemia (Neuroprotection Research Laboratory-MGH), which offered me the opportunity to extend my experience at a more basic and experimental level. I obtained a Miguel Servet position in 2010 from the Spanish National Institute of Health and Research Agency (Instituto Carlos III), and since February 2016 I hold a Tenure position at VHIR as Principal Investigator and since 2017 I am the head of the Neurovascular Research Laboratory. The main focus of my research is the search of new therapies for stroke patients based on neurorepair strategies with specific emphasis on the role of angio-vasculogenesis using nanomedicine and cell-therapy approaches for regenerative medicine. This has allowed me to obtain independent funding as PI from national agencies, Euronanomed program and private foundations, to supervise and guide PhD Students, Post-doctoral researchers, and establish national and International collaborations with other PIs in the neuroscience, regenerative medicine and nanotechnology fields. I do have the research accreditation of Associate Professor from AQU. My group has a distinction of Consolidated Research Group by AGAUR (2017SGR 1427) and belongs to the Spanish Cooperative Network for Research in Cerebrovascular Diseases (RICORS-2022).
Projects INVICTUS IP: Joan Montaner Villalonga Collaborators: Marta Aurora Rubiera Del Fueyo, Jorge Pagola Pérez Blanca, José Alvarez Sabin, Anna Penalba Morenilla, Maria Mar Hernandez Guillamon, Marc Ribó Jacobi, Maria Pilar Delgado Martínez, Carlos Molina Cateriano, Anna Rosell Novel, David Rodriguez Luna, Mª Ángeles Muchada López, Estevo Santamarina Pérez Funding agency: Instituto de Salud Carlos III Funding: 247695.66 Reference: RD12/0014/0005 Duration: 01/01/2013 - 31/03/2017 Influence of proteases before, during and after stroke (ERANET- PROTEA) IP: Joan Montaner Villalonga Collaborators: Anna Penalba Morenilla, Maria Pilar Delgado Martínez, Anna Rosell Novel Funding agency: Ministerio de Ciencia e Innovación-MICINN Funding: 150000 Reference: PRI-PIMNEU-2011-1352 (PROTEA) Duration: 01/12/2011 - 01/12/2014 Uso de nanopartículas magnéticas para la potenciación de la neuroreparación tras el ictus isquémico mediante la dirección localizada de células endoteliales progenitoras IP: Anna Rosell Novel Collaborators: - Funding agency: Instituto de Salud Carlos III Funding: 111320 Reference: PI10/00694 Duration: 01/01/2011 - 30/04/2014 Neurorepair Treatments for Cerebral Ischemia using Endothelial Progenitor Cells (EPCs) IP: Anna Rosell Novel Collaborators: - Funding agency: Instituto de Salud Carlos III Funding: 45000 Reference: CP09/00265 Duration: 01/01/2010 - 31/05/2013 Pagination First page « Previous page ‹ … Page 6 Page 7 Current page 8 Page 9 Page 10 … Next page › Last page »
